IL18 and diabetic kidney disease: Several studies have contributed to the development of molecular pathways in DKD, focusing on the role of innate immunity and on the different inflammatory mediators such as cytokines, especially interleukin 1 (IL-1), IL-6, IL-18, and different cell populations [3].